Cargando…

A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome

BACKGROUND: Up to half of patients with localized prostate cancer experience biochemical relapse within 10 years after definitive radiotherapy. The aim of this prospective study was to investigate the toxicity, dose to the organs at risk (OARs), and efficacy of dose-intensified focal salvage radioth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ryg, Una, Seierstad, Therese, Nilsen, Line Brennhaug, Hellebust, Taran Paulsen, Djupvik, Linda Holth, Gustafson, Hilde, Hydal, Jørgen, Kishan, Amar U., Hole, Knut Håkon, Lilleby, Wolfgang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022104/ https://www.ncbi.nlm.nih.gov/pubmed/35463376 http://dx.doi.org/10.3389/fonc.2022.861127

Ejemplares similares

Ablative Radiotherapy in Prostate Cancer: Stereotactic Body Radiotherapy and High Dose Rate Brachytherapy
por: Ma, Ting Martin, et al.
Publicado: (2020)

MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients
por: Mo, Torgeir, et al.
Publicado: (2023)

Monoparametric high-resolution diffusion weighted MRI as a possible first step in an MRI-directed diagnostic pathway for men with suspicion of prostate cancer
por: Reijnen, Jeroen Sebastiaan, et al.
Publicado: (2023)

Intrafractional motion in stereotactic body radiotherapy of spinal metastases utilizing cone beam computed tomography image guidance
por: Graadal Svestad, Jørund, et al.
Publicado: (2019)

Multimodal functional imaging for early response assessment in GIST patients treated with imatinib
por: Revheim, Mona-Elisabeth, et al.
Publicado: (2014)

Quantitative analysis of diffusion-weighted magnetic resonance imaging in malignant breast lesions using different b value combinations
por: Nilsen, Line B., et al.
Publicado: (2012)

Review of clinical brachytherapy uncertainties: Analysis guidelines of GEC-ESTRO and the AAPM()
por: Kirisits, Christian, et al.
Publicado: (2014)

Quality assurance in radiotherapy on a national level; experience from Norway: the KVIST initiative
por: Hellebust, Taran Paulsen, et al.
Publicado: (2013)

Routine pelvic MRI using phased-array coil for detection of extraprostatic tumour extension: accuracy and clinical significance
por: Hole, Knut Håkon, et al.
Publicado: (2012)

Comparison of time curves from dynamic (18)F-fluciclovine positron emission tomography and dynamic contrast-enhanced magnetic resonance imaging for primary prostate carcinomas
por: Tulipan, Andreas Julius, et al.
Publicado: (2018)

A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients
por: Salberg, Unn Beate, et al.
Publicado: (2022)

Stereotactic Body Radiotherapy for Prostate Cancer
por: Parikh, Neil R., et al.
Publicado: (2020)

A multicentre comparison of the dosimetric impact of inter- and intra-fractional anatomical variations in fractionated cervix cancer brachytherapy
por: Nesvacil, Nicole, et al.
Publicado: (2013)

Favorable outcomes in locally advanced and node positive prostate cancer patients treated with combined pelvic IMRT and androgen deprivation therapy
por: Lilleby, Wolfgang, et al.
Publicado: (2015)

Editorial: Stereotactic body radiotherapy for prostate cancer
por: Kishan, Amar U., et al.
Publicado: (2022)

Trends in Use and Comparison of Stereotactic Body Radiation Therapy, Brachytherapy, and Dose-Escalated External Beam Radiation Therapy for the Management of Localized, Intermediate-Risk Prostate Cancer
por: Nguyen, Kevin A., et al.
Publicado: (2020)

Results from a PI-RADS-based MRI-directed diagnostic pathway for biopsy-naive patients in a non-university hospital
por: Reijnen, Jeroen S., et al.
Publicado: (2021)

Stereotactic Body Radiotherapy as an Alternative to Brachytherapy in Gynecologic Cancer
por: Kubicek, Gregory J., et al.
Publicado: (2013)

Short-course PET based simultaneous integrated boost for locally advanced cervical cancer
por: Arnesen, Marius Røthe, et al.
Publicado: (2016)

Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer
por: Kalanxhi, Erta, et al.
Publicado: (2018)

Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer
por: Bains, Simer J., et al.
Publicado: (2019)

Dose deviations induced by respiratory motion for radiotherapy of lung tumors: Impact of CT reconstruction, plan complexity, and fraction size
por: Sande, Erlend P. S., et al.
Publicado: (2020)

Stereotactic Ablative Brachytherapy: Recent Advances in Optimization of Radiobiological Cancer Therapy
por: Xue, Hui, et al.
Publicado: (2021)

Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer
por: Guldvik, Ingrid Jenny, et al.
Publicado: (2021)

Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC
por: Li, Ranran, et al.
Publicado: (2017)

Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomography
por: Rusten, Espen, et al.
Publicado: (2017)

Stereotactic iodine-125 brachytherapy for brain tumors: temporary versus permanent implantation
por: Ruge, Maximilian I, et al.
Publicado: (2012)

Stereotactic body radiation therapy via helical tomotherapy to replace brachytherapy for brachytherapy-unsuitable cervical cancer patients – a preliminary result
por: Hsieh, Chen-Hsi, et al.
Publicado: (2013)

High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer
por: Abrahamsson, Hanna, et al.
Publicado: (2019)

Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible
por: Lee, Tae Hoon, et al.
Publicado: (2021)

Brachytherapy Versus Stereotactic Body Radiotherapy for Cervical Cancer Boost: A Dosimetric Comparison
por: Dahbi, Zineb, et al.
Publicado: (2023)

Measurements of carotid intima media thickness in non-invasive high-frequency ultrasound images: the effect of dynamic range setting
por: Gaarder, Mario, et al.
Publicado: (2015)

A retrospective study on unresectable or inoperable head and neck cancers treated with stereotactic ablative brachytherapy
por: Zhao, Genghao, et al.
Publicado: (2022)

Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging
por: Fangberget, A., et al.
Publicado: (2010)

Stereotactic body radiation therapy use for high risk prostate cancer in the United States
por: Patel, Sagar A., et al.
Publicado: (2020)

The occurrence and development of radiation-induced lung injury after interstitial brachytherapy and stereotactic radiotherapy in SD rats
por: Chen, Zhuo, et al.
Publicado: (2023)

Responses in the diffusivity and vascular function of the irradiated normal brain are seen up until 18 months following SRS of brain metastases
por: Nilsen, Line Brennhaug, et al.
Publicado: (2020)

Magnetic Resonance Imaging Guidance Mitigates the Effects of Intrafraction Prostate Motion During Stereotactic Body Radiotherapy for Prostate Cancer
por: Hegde, John V, et al.
Publicado: (2018)

Intracranial Ependymoma: Long-Term Results in a Series of 21 Patients Treated with Stereotactic (125)Iodine Brachytherapy
por: El Majdoub, Faycal, et al.
Publicado: (2012)

Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas
por: Watson, Juliana, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j2oinjidnd480bbfurou5v7teb